definiens: shall mean a li st identifying each ( a ) Antibody that [COMPANY] has selected, prior to the Ef fective Date, or selects on or after the Effective Date, as the subject of a Hu MAb Project ( and with respect to which [COMPANY] desires to reserve rights for the exercise thereof by [COMPANY] or the grant of a license by [COMPANY] to a [COMPANY] A ffiliate or a Third Party ) ; and ( b ) Selected Antibody ; provided, however, that with respect to any Antibody ( including any Selected Antibody ) with respect to w hich [COMPANY] has granted a license or other rights pursuant to an agreement en tered into with a Third Party prior to the Effective Date, the list shall identif y only those Antibodies ( or Selected Antibodies, as the case may be ) that have been or are disclosed to [COMPANY] in writing by such Third Party . For the avo idance of doubt, with respect to Antibodies selected after the Effective Date, th e Antibody Sequence List will contain such items which are added in accordance wi th Section 2.3.2(b)(iii ) hereof